![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Mark R. Charbonneau, Vincent M. Isabella, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 297
Mark R. Charbonneau, Vincent M. Isabella, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 297
Showing 1-25 of 297 citing articles:
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1648
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1648
The evolution of commercial drug delivery technologies
Ava M. Vargason, Aaron C. Anselmo, Samir Mitragotri
Nature Biomedical Engineering (2021) Vol. 5, Iss. 9, pp. 951-967
Open Access | Times Cited: 895
Ava M. Vargason, Aaron C. Anselmo, Samir Mitragotri
Nature Biomedical Engineering (2021) Vol. 5, Iss. 9, pp. 951-967
Open Access | Times Cited: 895
The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 816
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 816
Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 336
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 336
Function and therapeutic value of astrocytes in neurological diseases
Hong‐Gyun Lee, Michael A. Wheeler, Francisco J. Quintana
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 5, pp. 339-358
Open Access | Times Cited: 319
Hong‐Gyun Lee, Michael A. Wheeler, Francisco J. Quintana
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 5, pp. 339-358
Open Access | Times Cited: 319
Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
Jun Zhou, Maoyi Li, Qiufang Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 312
Jun Zhou, Maoyi Li, Qiufang Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 312
Engineering living therapeutics with synthetic biology
Andrés Cubillos-Ruiz, Tingxi Guo, Anna Sokolovska, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 12, pp. 941-960
Closed Access | Times Cited: 207
Andrés Cubillos-Ruiz, Tingxi Guo, Anna Sokolovska, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 12, pp. 941-960
Closed Access | Times Cited: 207
Engineering Bacteria‐Activated Multifunctionalized Hydrogel for Promoting Diabetic Wound Healing
Yifei Lü, Haisheng Li, Jing Wang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 48
Closed Access | Times Cited: 168
Yifei Lü, Haisheng Li, Jing Wang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 48
Closed Access | Times Cited: 168
Applications, challenges, and needs for employing synthetic biology beyond the lab
Sierra M. Brooks, Hal S. Alper
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 165
Sierra M. Brooks, Hal S. Alper
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 165
A programmable encapsulation system improves delivery of therapeutic bacteria in mice
Tetsuhiro Harimoto, Jaeseung Hahn, Yuyu Chen, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 8, pp. 1259-1269
Open Access | Times Cited: 157
Tetsuhiro Harimoto, Jaeseung Hahn, Yuyu Chen, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 8, pp. 1259-1269
Open Access | Times Cited: 157
Foundations of gastrointestinal-based drug delivery and future developments
Jacqueline N. Chu, Giovanni Traverso
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 4, pp. 219-238
Closed Access | Times Cited: 135
Jacqueline N. Chu, Giovanni Traverso
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 4, pp. 219-238
Closed Access | Times Cited: 135
Leveraging diet to engineer the gut microbiome
Mathis Wolter, Erica T. Grant, Marie Boudaud, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 885-902
Open Access | Times Cited: 134
Mathis Wolter, Erica T. Grant, Marie Boudaud, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 885-902
Open Access | Times Cited: 134
Recent advances on endogenous/exogenous stimuli-triggered nanoplatforms for enhanced chemodynamic therapy
Qianqian Sun, Zhao Wang, Bin Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 451, pp. 214267-214267
Closed Access | Times Cited: 133
Qianqian Sun, Zhao Wang, Bin Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 451, pp. 214267-214267
Closed Access | Times Cited: 133
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Sidhanth Chandra, Sangram S. Sisodia, Robert Vassar
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 128
Sidhanth Chandra, Sangram S. Sisodia, Robert Vassar
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 128
Cell therapies in the clinic
Liwen Wang, Morgan E. Janes, Ninad Kumbhojkar, et al.
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 104
Liwen Wang, Morgan E. Janes, Ninad Kumbhojkar, et al.
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 104
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Jason P. Lynch, Lisa Goers, Cammie F. Lesser
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 772-786
Open Access | Times Cited: 94
Jason P. Lynch, Lisa Goers, Cammie F. Lesser
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 772-786
Open Access | Times Cited: 94
Decorated bacteria and the application in drug delivery
Feng Wu, Jinyao Liu
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114443-114443
Closed Access | Times Cited: 86
Feng Wu, Jinyao Liu
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114443-114443
Closed Access | Times Cited: 86
An Engineered Bacteria-Hybrid Microrobot with the Magnetothermal Bioswitch for Remotely Collective Perception and Imaging-Guided Cancer Treatment
Haotian Chen, Yingze Li, Yanjin Wang, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6118-6133
Closed Access | Times Cited: 79
Haotian Chen, Yingze Li, Yanjin Wang, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6118-6133
Closed Access | Times Cited: 79
Genomically mined acoustic reporter genes for real-time in vivo monitoring of tumors and tumor-homing bacteria
Robert C. Hurt, Marjorie T. Buss, Mengtong Duan, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 919-931
Open Access | Times Cited: 76
Robert C. Hurt, Marjorie T. Buss, Mengtong Duan, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 7, pp. 919-931
Open Access | Times Cited: 76
Oral drug delivery platforms for biomedical applications
Jiang Ouyang, Zhongyang Zhang, Bo Deng, et al.
Materials Today (2023) Vol. 62, pp. 296-326
Closed Access | Times Cited: 69
Jiang Ouyang, Zhongyang Zhang, Bo Deng, et al.
Materials Today (2023) Vol. 62, pp. 296-326
Closed Access | Times Cited: 69
Applications of synthetic biology in medical and pharmaceutical fields
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 59
The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
Kelly Fogelson, Pieter C. Dorrestein, Amir Zarrinpar, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1069-1085
Open Access | Times Cited: 58
Kelly Fogelson, Pieter C. Dorrestein, Amir Zarrinpar, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1069-1085
Open Access | Times Cited: 58
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Jason J. Luke, Sarina A. Piha‐Paul, Theresa Medina, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 13, pp. 2435-2444
Open Access | Times Cited: 56
Jason J. Luke, Sarina A. Piha‐Paul, Theresa Medina, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 13, pp. 2435-2444
Open Access | Times Cited: 56
Synthetic microbial communities (SynComs) of the human gut: design, assembly, and applications
Pim J. van Leeuwen, Stanley Brul, Jianbo Zhang, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 51
Pim J. van Leeuwen, Stanley Brul, Jianbo Zhang, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 2
Open Access | Times Cited: 51
AIEgens for microorganism‐related visualization and therapy
Ziyue Ye, Wei He, Zicong Zhang, et al.
Deleted Journal (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 42
Ziyue Ye, Wei He, Zicong Zhang, et al.
Deleted Journal (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 42